APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Active Pharmaceutical Ingredients (API)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Active Pharmaceutical Ingredients (API) Market Outlook and Growth Opportunities 2026

Report ID 174045860421 December 2025194 pages

Choose your research edition.

Industry ResearchVeterinary Active Pharmaceutical Ingredients (API) Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Active Pharmaceutical Ingredients (API) Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Veterinary Active Pharmaceutical Ingredients (API) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Active Pharmaceutical Ingredients (API) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Active Pharmaceutical Ingredients (API) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Veterinary Active Pharmaceutical Ingredients (API) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Active Pharmaceutical Ingredients (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Active Pharmaceutical Ingredients (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Active Pharmaceutical Ingredients (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Active Pharmaceutical Ingredients (API) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Active Pharmaceutical Ingredients (API) market include Qilu Pharmaceutical (Inner Mongolia) Co, Ltd, Jiangsu Lingyun Pharmaceutical Co. Ltd, SUANFARMAOfichem Group, Procyon Life Sciences, NGL Fine-Chem Ltd, Menadiona, lndukern Group, LasaSupergenerics Ltd. and Huvepharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary Active Pharmaceutical Ingredients (API) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Active Pharmaceutical Ingredients (API) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Active Pharmaceutical Ingredients (API) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Active Pharmaceutical Ingredients (API) market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Active Pharmaceutical Ingredients (API) Segment by Company

Qilu Pharmaceutical (Inner Mongolia) Co, Ltd

Jiangsu Lingyun Pharmaceutical Co. Ltd

SUANFARMAOfichem Group

Procyon Life Sciences

NGL Fine-Chem Ltd

Menadiona

lndukern Group

LasaSupergenerics Ltd.

Huvepharma

Excel Veterinary HealthcareVetpharma(Insud Pharma)

Alivira Animal Health Ltd

Veterinary Active Pharmaceutical Ingredients (API) Segment by Type

Biological API

Chemical Based API

Highly Potent APl(HPAPI)

Veterinary Active Pharmaceutical Ingredients (API) Segment by Application

CDMO

CMO

Veterinary Active Pharmaceutical Ingredients (API) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Veterinary Active Pharmaceutical Ingredients (API) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Veterinary Active Pharmaceutical Ingredients (API) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Active Pharmaceutical Ingredients (API) significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Active Pharmaceutical Ingredients (API) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Active Pharmaceutical Ingredients (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Active Pharmaceutical Ingredients (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Active Pharmaceutical Ingredients (API).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Active Pharmaceutical Ingredients (API) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Active Pharmaceutical Ingredients (API) industry.

Chapter 3: Detailed analysis of Veterinary Active Pharmaceutical Ingredients (API) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Veterinary Active Pharmaceutical Ingredients (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Veterinary Active Pharmaceutical Ingredients (API) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Active Pharmaceutical Ingredients (API) Industry Trends Table 2. Veterinary Active Pharmaceutical Ingredients (API) Industry Drivers Table 3. Veterinary Active Pharmaceutical Ingredients (API) Industry Opportunities and Challenges Table 4. Veterinary Active Pharmaceutical Ingredients (API) Industry Restraints Table 5. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Company (2021-2026) Table 7. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Company (k units) & (2021-2026) Table 8. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Share by Company (2021-2026) Table 9. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price (US$/unit) of Company (2021-2026) Table 10. Global Veterinary Active Pharmaceutical Ingredients (API) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Veterinary Active Pharmaceutical Ingredients (API) Key Company Manufacturing Base & Headquarters Table 12. Global Veterinary Active Pharmaceutical Ingredients (API) Company, Product Type & Application Table 13. Global Veterinary Active Pharmaceutical Ingredients (API) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Active Pharmaceutical Ingredients (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Biological API Table 18. Significant Companies of Chemical Based API Table 19. Significant Companies of Highly Potent APl(HPAPI) Table 20. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Type (2021-2026) & (k units) Table 22. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Type (2027-2032) & (k units) Table 23. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Share by Type (2021-2026) Table 24. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Share by Type (2027-2032) Table 25. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type (2021-2026) Table 29. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of CDMO Table 31. Significant Companies of CMO Table 32. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Application (2021-2026) & (k units) Table 34. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Application (2027-2032) & (k units) Table 35. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2021-2026) Table 36. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2027-2032) Table 37. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application (2021-2026) Table 41. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application (2027-2032) Table 42. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2021-2026) & (k units) Table 44. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2021-2026) Table 45. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2027-2032) & (k units) Table 46. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2027-2032) Table 47. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Region (2021-2026) Table 50. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Region (2027-2032) Table 52. Global Veterinary Active Pharmaceutical Ingredients (API) Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Veterinary Active Pharmaceutical Ingredients (API) Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (k units) Table 57. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2021-2026) Table 58. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032) & (k units) Table 59. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2027-2032) Table 60. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Market Share by Country (2021-2026) Table 62. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Market Share by Country (2027-2032) Table 64. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Information Table 65. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Business Overview Table 66. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 68. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Development Table 69. Jiangsu Lingyun Pharmaceutical Co. Ltd Company Information Table 70. Jiangsu Lingyun Pharmaceutical Co. Ltd Business Overview Table 71. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 73. Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Development Table 74. SUANFARMAOfichem Group Company Information Table 75. SUANFARMAOfichem Group Business Overview Table 76. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 78. SUANFARMAOfichem Group Recent Development Table 79. Procyon Life Sciences Company Information Table 80. Procyon Life Sciences Business Overview Table 81. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 83. Procyon Life Sciences Recent Development Table 84. NGL Fine-Chem Ltd Company Information Table 85. NGL Fine-Chem Ltd Business Overview Table 86. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 88. NGL Fine-Chem Ltd Recent Development Table 89. Menadiona Company Information Table 90. Menadiona Business Overview Table 91. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 93. Menadiona Recent Development Table 94. lndukern Group Company Information Table 95. lndukern Group Business Overview Table 96. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 98. lndukern Group Recent Development Table 99. LasaSupergenerics Ltd. Company Information Table 100. LasaSupergenerics Ltd. Business Overview Table 101. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 103. LasaSupergenerics Ltd. Recent Development Table 104. Huvepharma Company Information Table 105. Huvepharma Business Overview Table 106. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 108. Huvepharma Recent Development Table 109. Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Information Table 110. Excel Veterinary HealthcareVetpharma(Insud Pharma) Business Overview Table 111. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 113. Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Development Table 114. Alivira Animal Health Ltd Company Information Table 115. Alivira Animal Health Ltd Business Overview Table 116. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 118. Alivira Animal Health Ltd Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Veterinary Active Pharmaceutical Ingredients (API) Distributors List Table 122. Veterinary Active Pharmaceutical Ingredients (API) Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Veterinary Active Pharmaceutical Ingredients (API) Product Image Figure 2. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (2021-2032) & (k units) Figure 5. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Veterinary Active Pharmaceutical Ingredients (API) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Biological API Image Figure 10. Chemical Based API Image Figure 11. Highly Potent APl(HPAPI) Image Figure 12. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Share by Type (2021-2032) Figure 15. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type (2021-2032) Figure 18. CDMO Image Figure 19. CMO Image Figure 20. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2021-2032) Figure 23. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application (2021-2032) Figure 26. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Value (2021-2032) & (US$ Million) Figure 31. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Value (2021-2032) & (US$ Million) Figure 37. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Veterinary Active Pharmaceutical Ingredients (API) Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Veterinary Active Pharmaceutical Ingredients (API) Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Biological API
  • Chemical Based API
  • Highly Potent APl(HPAPI)
Applications
  • CDMO
  • CMO
Companies covered
  • Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
  • Jiangsu Lingyun Pharmaceutical Co. Ltd
  • SUANFARMAOfichem Group
  • Procyon Life Sciences
  • NGL Fine-Chem Ltd
  • Menadiona
  • lndukern Group
  • LasaSupergenerics Ltd.
  • Huvepharma
  • Excel Veterinary HealthcareVetpharma(Insud Pharma)
  • Alivira Animal Health Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value (2021-2032)
  4. 1.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume (2021-2032)
  5. 1.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Veterinary Active Pharmaceutical Ingredients (API) Market Dynamics
  1. 2.1 Veterinary Active Pharmaceutical Ingredients (API) Industry Trends
  2. 2.2 Veterinary Active Pharmaceutical Ingredients (API) Industry Drivers
  3. 2.3 Veterinary Active Pharmaceutical Ingredients (API) Industry Opportunities and Challenges
  4. 2.4 Veterinary Active Pharmaceutical Ingredients (API) Industry Restraints
3 Veterinary Active Pharmaceutical Ingredients (API) Market by Company
  1. 3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Company (2021-2026)
  4. 3.4 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Company (2021-2026)
  5. 3.5 Global Veterinary Active Pharmaceutical Ingredients (API) Company Ranking (2024-2026)
  6. 3.6 Global Veterinary Active Pharmaceutical Ingredients (API) Company Manufacturing Base and Headquarters
  7. 3.7 Global Veterinary Active Pharmaceutical Ingredients (API) Company Product Type and Application
  8. 3.8 Global Veterinary Active Pharmaceutical Ingredients (API) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Veterinary Active Pharmaceutical Ingredients (API) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Veterinary Active Pharmaceutical Ingredients (API) Market by Type
  1. 4.1 Veterinary Active Pharmaceutical Ingredients (API) Type Introduction
  2. 4.1.1 Biological API
  3. 4.1.2 Chemical Based API
  4. 4.1.3 Highly Potent APl(HPAPI)
  5. 4.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Type
  6. 4.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Type
  10. 4.3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type (2021-2032)
5 Veterinary Active Pharmaceutical Ingredients (API) Market by Application
  1. 5.1 Veterinary Active Pharmaceutical Ingredients (API) Application Introduction
  2. 5.1.1 CDMO
  3. 5.1.2 CMO
  4. 5.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Application
  5. 5.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Application
  9. 5.3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Application (2021-2032)
  11. 5.3.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application (2021-2032)
6 Veterinary Active Pharmaceutical Ingredients (API) Regional Sales and Value Analysis
  1. 6.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2021-2026
  4. 6.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2027-2032)
  5. 6.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Region (2027-2032)
  9. 6.5 Global Veterinary Active Pharmaceutical Ingredients (API) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Veterinary Active Pharmaceutical Ingredients (API) Sales Value (2021-2032)
  12. 6.6.2 North America Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Value (2021-2032)
  15. 6.7.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Veterinary Active Pharmaceutical Ingredients (API) Sales Value (2021-2032)
  21. 6.9.2 South America Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Country, 2025 VS 2032
7 Veterinary Active Pharmaceutical Ingredients (API) Country-level Sales and Value Analysis
  1. 7.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2032)
  4. 7.3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026)
  5. 7.3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032)
  6. 7.4 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Veterinary Active Pharmaceutical Ingredients (API) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Veterinary Active Pharmaceutical Ingredients (API) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
  2. 8.1.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Information
  3. 8.1.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Business Overview
  4. 8.1.3 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  6. 8.1.5 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments
  7. 8.2 Jiangsu Lingyun Pharmaceutical Co. Ltd
  8. 8.2.1 Jiangsu Lingyun Pharmaceutical Co. Ltd Company Information
  9. 8.2.2 Jiangsu Lingyun Pharmaceutical Co. Ltd Business Overview
  10. 8.2.3 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  12. 8.2.5 Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments
  13. 8.3 SUANFARMAOfichem Group
  14. 8.3.1 SUANFARMAOfichem Group Company Information
  15. 8.3.2 SUANFARMAOfichem Group Business Overview
  16. 8.3.3 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  18. 8.3.5 SUANFARMAOfichem Group Recent Developments
  19. 8.4 Procyon Life Sciences
  20. 8.4.1 Procyon Life Sciences Company Information
  21. 8.4.2 Procyon Life Sciences Business Overview
  22. 8.4.3 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  24. 8.4.5 Procyon Life Sciences Recent Developments
  25. 8.5 NGL Fine-Chem Ltd
  26. 8.5.1 NGL Fine-Chem Ltd Company Information
  27. 8.5.2 NGL Fine-Chem Ltd Business Overview
  28. 8.5.3 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  30. 8.5.5 NGL Fine-Chem Ltd Recent Developments
  31. 8.6 Menadiona
  32. 8.6.1 Menadiona Company Information
  33. 8.6.2 Menadiona Business Overview
  34. 8.6.3 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  36. 8.6.5 Menadiona Recent Developments
  37. 8.7 lndukern Group
  38. 8.7.1 lndukern Group Company Information
  39. 8.7.2 lndukern Group Business Overview
  40. 8.7.3 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  42. 8.7.5 lndukern Group Recent Developments
  43. 8.8 LasaSupergenerics Ltd.
  44. 8.8.1 LasaSupergenerics Ltd. Company Information
  45. 8.8.2 LasaSupergenerics Ltd. Business Overview
  46. 8.8.3 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  48. 8.8.5 LasaSupergenerics Ltd. Recent Developments
  49. 8.9 Huvepharma
  50. 8.9.1 Huvepharma Company Information
  51. 8.9.2 Huvepharma Business Overview
  52. 8.9.3 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  54. 8.9.5 Huvepharma Recent Developments
  55. 8.10 Excel Veterinary HealthcareVetpharma(Insud Pharma)
  56. 8.10.1 Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Information
  57. 8.10.2 Excel Veterinary HealthcareVetpharma(Insud Pharma) Business Overview
  58. 8.10.3 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  60. 8.10.5 Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments
  61. 8.11 Alivira Animal Health Ltd
  62. 8.11.1 Alivira Animal Health Ltd Company Information
  63. 8.11.2 Alivira Animal Health Ltd Business Overview
  64. 8.11.3 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  66. 8.11.5 Alivira Animal Health Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Active Pharmaceutical Ingredients (API) Value Chain Analysis
  2. 9.1.1 Veterinary Active Pharmaceutical Ingredients (API) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Active Pharmaceutical Ingredients (API) Sales Mode & Process
  6. 9.2 Veterinary Active Pharmaceutical Ingredients (API) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Active Pharmaceutical Ingredients (API) Distributors
  9. 9.2.3 Veterinary Active Pharmaceutical Ingredients (API) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst